Author Index

Artikel in diesem Heft

1. Initiation and progression of atherosclerosis – enzymatic or oxidative modification of low-density lipoprotein?
2. Blood transfusions in athletes. Old dogmas, new tricks
3. Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics
4. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR
5. Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations
6. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography
7. Point-of-care C-reactive protein testing in febrile children in general practice
8. Improvement in HPLC separation of porphyrin isomers and application to biochemical diagnosis of porphyrias
9. Measurement of late-night salivary cortisol with an automated immunoassay system
10. Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse
11. Stone or stricture as a cause of extrahepatic cholestasis – do liver function tests predict the diagnosis?
12. Insulin resistance and enhanced protein glycation in men with prehypertension
13. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
14. Analytical performance and clinical utility of the INNOTEST^® PHOSPHO-TAU_(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
15. Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls
16. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT)
17. National survey on the pre-analytical variability in a representative cohort of Italian laboratories
18. 10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data
19. Biological variation of non-SI traceable biological quantities: example of proteins
20. Effect of tibolone therapy on lipids and coagulation indices
21. Acknowledgement
22. Contents Volume 44, 2006
23. Author Index
24. Subject Index